Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The phosphorylated prodrug FTY720 is a histone deacetylase inhibitor that reactivates ERα expression and enhances hormonal therapy for breast cancer
Nitai C. Hait, Dorit Avni, Akimitsu Yamada, et al.
Oncogenesis (2015) Vol. 4, Iss. 6, pp. e156-e156
Open Access | Times Cited: 95

Showing 1-25 of 95 citing articles:

Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential
Masayo Aoki, Hiroaki Aoki, Rajesh Ramanathan, et al.
Mediators of Inflammation (2016) Vol. 2016, pp. 1-11
Open Access | Times Cited: 186
Targeting the SphK1/S1P/S1PR1 Axis That Links Obesity, Chronic Inflammation, and Breast Cancer Metastasis
Masayuki Nagahashi, Akimitsu Yamada, Eriko Katsuta, et al.
Cancer Research (2018) Vol. 78, Iss. 7, pp. 1713-1725
Open Access | Times Cited: 176
Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advances
Susan Pyne, David R. Adams, Nigel J. Pyne
Progress in Lipid Research (2016) Vol. 62, pp. 93-106
Open Access | Times Cited: 170
Regulation of cellular and systemic sphingolipid homeostasis
Andrew Kuo, Timothy Hla
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 10, pp. 802-821
Closed Access | Times Cited: 18
Altering phosphorylation in cancer through PP2A modifiers
Hannah Johnson, Satya Narayan, Arun Sharma
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 16
The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer
Nitai C. Hait, Aparna Maiti
Mediators of Inflammation (2017) Vol. 2017, pp. 1-17
Open Access | Times Cited: 163
Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
Katherine Stockstill, Timothy M. Doyle, Xisheng Yan, et al.
The Journal of Experimental Medicine (2018) Vol. 215, Iss. 5, pp. 1301-1313
Open Access | Times Cited: 130
Lipidomics in translational research and the clinical significance of lipid-based biomarkers
Daniel Stephenson, L. Alexis Hoeferlin, Charles E. Chalfant
Translational research (2017) Vol. 189, pp. 13-29
Open Access | Times Cited: 117
The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy
Susan G. Dorsey, Ian R. Kleckner, Debra L. Barton, et al.
JNCI Journal of the National Cancer Institute (2019) Vol. 111, Iss. 6, pp. 531-537
Open Access | Times Cited: 113
The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases
Masayuki Nagahashi, Kizuki Yuza, Yuki Hirose, et al.
Journal of Lipid Research (2016) Vol. 57, Iss. 9, pp. 1636-1643
Open Access | Times Cited: 100
Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget
Diana Hatoum, Nahal Haddadi, Yiguang Lin, et al.
Oncotarget (2017) Vol. 8, Iss. 22, pp. 36898-36929
Open Access | Times Cited: 91
Tamoxifen Action in ER-Negative Breast Cancer
Subrata Manna, Marina K. Holz
Signal Transduction Insights (2016) Vol. 5, pp. STI.S29901-STI.S29901
Open Access | Times Cited: 87
Targeting the S1P/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation
Shaness A. Grenald, Timothy M. Doyle, Hong Zhang, et al.
Pain (2017) Vol. 158, Iss. 9, pp. 1733-1742
Open Access | Times Cited: 65
Targeting sphingosine-1-phosphate signaling in lung diseases
David L. Ebenezer, Panfeng Fu, Viswanathan Natarajan
Pharmacology & Therapeutics (2016) Vol. 168, pp. 143-157
Open Access | Times Cited: 62
Epigenetic regulation of pro-inflammatory cytokine secretion by sphingosine 1-phosphate (S1P) in acute lung injury: Role of S1P lyase
David L. Ebenezer, Panfeng Fu, Vidyani Suryadevara, et al.
Advances in Biological Regulation (2016) Vol. 63, pp. 156-166
Open Access | Times Cited: 61
S1PR1 as a Novel Promising Therapeutic Target in Cancer Therapy
Narges Rostami, Afshin Nikkhoo, Amir Ajjoolabady, et al.
Molecular Diagnosis & Therapy (2019) Vol. 23, Iss. 4, pp. 467-487
Closed Access | Times Cited: 57
Recent advances in the role of sphingosine 1‐phosphate in cancer
Nigel J. Pyne, Susan Pyne
FEBS Letters (2020) Vol. 594, Iss. 22, pp. 3583-3601
Open Access | Times Cited: 51
Targeting Sphingolipids for Cancer Therapy
Osmel Companioni, Cristina Mir, Yoelsis García-Mayea, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 50
Molecular Pharmacology and Novel Potential Therapeutic Applications of Fingolimod
Safura Pournajaf, Leila Dargahi, Mohammad Javan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 34
PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives
Yalong Qi, Lixi Li, Yuhan Wei, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116398-116398
Open Access | Times Cited: 7
Targeting Sphingosine-1-Phosphate Signaling in Breast Cancer
Masayuki Nagahashi, Yasuo Miyoshi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3354-3354
Open Access | Times Cited: 6
Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival
Aparna Maiti, Kazuaki Takabe, Nitai C. Hait
Cellular Signalling (2017) Vol. 32, pp. 85-92
Open Access | Times Cited: 59
Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming
Olga Sukocheva
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 2, pp. 420-420
Open Access | Times Cited: 57
Doxorubicin effect is enhanced by sphingosine-1-phosphate signaling antagonist in breast cancer
Eriko Katsuta, Li Yan, Masayuki Nagahashi, et al.
Journal of Surgical Research (2017) Vol. 219, pp. 202-213
Open Access | Times Cited: 52
FTY720/fingolimod decreases hepatic steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice
Timothy D. Rohrbach, Amon Asgharpour, Melissa A. Maczis, et al.
Journal of Lipid Research (2019) Vol. 60, Iss. 7, pp. 1311-1322
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top